Subject: Science and tech Context: Itolizumab, a monoclonal antibody used to treat acute psoriasis has got regulatory approval to treat cytokine release syndrome (CRS) in moderate to severe acute respiratory distress syndrome patients due to COVID-19. Concept: Psoriasis is a skin disease that causes red, itchy scaly patches, most commonly on the knees, elbows, trunk […]